---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-086150"
form_type: "8-K"
ticker: "OSTX"
cik: "0001795091"
company_name: "OS Therapies Inc"
filed_at: "2026-08-06T20:13:01+00:00"
generated_at: "2026-08-06T20:18:00.201475+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# OS Therapies settles $10M Leonite note for $1.9M cash + 500k shares; issues $2.2M bridge note

## Summary
- On July 31, 2026, OS Therapies agreed to pay Leonite $1.9M cash and issue 500,000 shares to fully satisfy the $10M secured convertible note (only $1.6M drawn).
- The settlement cancels the warrant to purchase 1.75M shares at $2.85 and 275,000 commitment shares; all security interests are released.
- To fund the settlement, on Aug 2, 2026, the company issued a $2.2M bridge convertible note (purchase price $2.19M) to an accredited investor, maturing Sept 1, 2026.
- The bridge note automatically converts into a future private offering of up to $10M; proceeds used for settlement and working capital.
- Settlement expected to close by Aug 7, 2026; shares to be issued under effective S-3 registration statement.

## SEC filing metadata
- accession: 0001213900-26-086150
- form_type: 8-K
- ticker: OSTX
- cik: 0001795091
- company_name: OS Therapies Inc
- filed_at: 2026-08-06T20:13:01+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1795091/000121390026086150/0001213900-26-086150-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1795091/000121390026086150/ea0300848-8k_ostherapies.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-086150
- JSON: https://secwatch.observer/filing/0001213900-26-086150.json
- Plain text: https://secwatch.observer/filing/0001213900-26-086150.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.